Gong, Inna Y <br/><br/>
Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiation.  [electronic resource] 

 -  PloS one  2011 
 - e27808 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0027808  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Algorithms<br/>Anticoagulants--pharmacokinetics<br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Blood Coagulation--drug effects<br/>Cytochrome P-450 CYP2C9<br/>Cytochrome P-450 Enzyme System--genetics<br/>Cytochrome P450 Family 4<br/>Dose-Response Relationship, Drug<br/>Female<br/>Gene Frequency<br/>Genotype<br/>Humans<br/>Kidney Function Tests<br/>Male<br/>Middle Aged<br/>Mixed Function Oxygenases--genetics<br/>Prospective Studies<br/>Tissue Distribution<br/>Vitamin K--metabolism<br/>Vitamin K Epoxide Reductases<br/>Warfarin--pharmacokinetics<br/>Young Adult